Cure My Disease

Don't miss your cure!

 Log in / Sign up

Short psychological intervention could ease Prisoners' anxiety and depression

NCT ID NCT05927987

Completed Symptom relief Sponsor: VU University of Amsterdam Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This pilot study tests whether a brief psychological program called Problem Management Plus (PM+) can help reduce anxiety and depression symptoms in people held in Dutch remand prisons. The program, developed by the World Health Organization, teaches problem-solving, stress management, and social support skills over five sessions. Researchers will compare prisoners who receive PM+ plus usual care to those who receive only usual care, focusing on whether the program is feasible and acceptable in this setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Problem Management Plus (PM+)
What this could lead to
If successful, this could provide a practical, low-cost mental health support option for prisoners, reducing symptoms of anxiety and depression.
What could go wrong
This is a small pilot study (56 participants) focused on feasibility, not effectiveness. Results may not generalize to other prisons or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS DEPRESSIVE DISORDER PSYCHOLOGICAL DISTRESS

Contacts and locations

Locations

  • Vrije Universiteit Amsterdam

    Amsterdam, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.